Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124000852 | 12400085 | 2 | F | 2006 | 20160629 | 20160524 | 20160707 | EXP | US-ASTRAZENECA-2006BM17379 | ASTRAZENECA | 48.00 | YR | F | Y | 152.40000 | KG | 20160707 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124000852 | 12400085 | 1 | PS | BYETTA | EXENATIDE | 1 | Subcutaneous | 10 MCG, TWO TIMES A DAY | Y | U | FL0208 | 21773 | SOLUTION FOR INJECTION IN PRE-FILLED PEN | ||||||
| 124000852 | 12400085 | 2 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | 5 MCG, TWO TIMES A DAY | Y | U | FL0208 | 21773 | SOLUTION FOR INJECTION IN PRE-FILLED PEN | ||||||
| 124000852 | 12400085 | 3 | SS | BYDUREON | EXENATIDE | 1 | Subcutaneous | U | 0 | 2 | MG | /wk | |||||||
| 124000852 | 12400085 | 4 | C | LANTUS | INSULIN GLARGINE | 1 | UNK | 0 | |||||||||||
| 124000852 | 12400085 | 5 | C | HUMALOG | INSULIN LISPRO | 1 | Subcutaneous | 25/75, 50 IU BID | 0 | ||||||||||
| 124000852 | 12400085 | 6 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | 1000 | MG | Q12H | ||||||||
| 124000852 | 12400085 | 7 | C | PREDNISONE. | PREDNISONE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124000852 | 12400085 | 1 | Type 2 diabetes mellitus |
| 124000852 | 12400085 | 2 | Type 2 diabetes mellitus |
| 124000852 | 12400085 | 5 | Type 2 diabetes mellitus |
| 124000852 | 12400085 | 6 | Type 2 diabetes mellitus |
| 124000852 | 12400085 | 7 | Sinusitis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124000852 | 12400085 | HO |
| 124000852 | 12400085 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124000852 | 12400085 | Blood glucose increased | |
| 124000852 | 12400085 | Device use issue | |
| 124000852 | 12400085 | Drug dose omission | |
| 124000852 | 12400085 | Drug ineffective | |
| 124000852 | 12400085 | Generalised tonic-clonic seizure | |
| 124000852 | 12400085 | Hyperglycaemia | |
| 124000852 | 12400085 | Injection site pain | |
| 124000852 | 12400085 | Injection site pruritus | |
| 124000852 | 12400085 | Intentional product misuse | |
| 124000852 | 12400085 | Overweight | |
| 124000852 | 12400085 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124000852 | 12400085 | 1 | 20060829 | 0 | ||
| 124000852 | 12400085 | 2 | 20060709 | 0 | ||
| 124000852 | 12400085 | 3 | 20160407 | 0 | ||
| 124000852 | 12400085 | 4 | 20060709 | 0 | ||
| 124000852 | 12400085 | 5 | 201601 | 0 | ||
| 124000852 | 12400085 | 6 | 1986 | 0 | ||
| 124000852 | 12400085 | 7 | 201604 | 0 |